Nevro plays down impact from UnitedHealth coverage decision

Oct. 10, 2022 7:31 AM ETNevro Corp. (NVRO)UNHBy: Dulan Lokuwithana, SA News Editor

Back pain-conceptual artwork-3d illustration

peterschreiber.media/iStock via Getty Images

  • Healthcare equipment maker Nevro Corp. (NYSE:NVRO) announced Monday that the recent decision by UnitedHealthcare (UNH) to limit coverage for spinal cord stimulation (SCS) devices is unlikely to have a material impact on its future

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.